CAR	Chimeric antigen receptor
TME	Tumor microenvironment
ACT	Adoptive T-cell transfer
MHC	Major histocompatibility complex
TAA	Tumor-associated antigen
FasL	Fas ligand
TRAIL	Tumor necrosis factor-related apoptosis-inducing ligand
FDA	The Food and Drug Administration
EMA	The European Medicines Agency
EGFR	Epidermal growth factor receptor
HER2	Human epidermal growth factor receptor 2
HNSCC	Head and neck squamous cell carcinoma
CEA	Carcinoembryonic antigen
PSMA	Prostate-specific membrane antigen
scFv	Single-chain variable fragment
CD	Cluster of differentiation
NSCLC	Non-small-cell lung cancers
OS	Overall survival
PD-1	Programmed cell death-1
PFS	Progression-free survival
CSD	Co-stimulatory domain
IL	Interleukin
CRISPR	Clustered regularly interspaced short palindromic repeats
TCR	T-cell receptor
CLL	Chronic lymphocytic leukemia
ALL	Acute lymphoblastic leukemia
DLBCL	Diffuse large B-cell lymphoma
TNBC	Triple-negative breast cancer
TLR4	Toll-like receptor 4
DCs	Dendritic cells
DAMPs	Damage-associated molecular patterns
HMGB1	High-mobility group box 1
IFN-I	Type I interferon
Tregs	Regulatory T cells
MDSC	Myeloid-derived suppressor cells
TGF-β	Transforming growth factor-Β
EOC	Epithelial ovarian cancer
CTX	Cyclophosphamide
M6P	Mannose-6-phosphate
HLA	Human leukocyte antigen
APCs	Antigen-presenting cells
BCMA	B-Cell maturation antigen
CPIs	Checkpoint inhibitors
DNR	PD-1 dominant negative receptor
shRNA	Short hairpin RNA
A2ARs	Adenosine 2A receptors
CTLA-4	Cytotoxic T-lymphocyte associated protein 4
PDCD1	Programmed cell death protein 1
TRAC	T-Cell receptor alpha constant
BiTEs	Bispecific T-Cell engager
HDAC	Histone deacetylase